1. Use L5 source (river-bed protein of major leishmaniasis) for pharmaceuticals to treat or prevent or delay parasitic diseases in patients； include the synthesis of the source； diagnose parasitic diseases in patients； use Diag And his equipment.
ALONSO BEDATE, CARLOS,SOTO ALVAREZ, MANUEL,RAMIREZ GARCIA, LAURA
申请号：
CL2012001249
公开号：
CL2012001249A1
申请日:
2012.05.11
申请国别(地区):
CL
年份:
2012
代理人:
摘要：
Use of a source of L3 and / or L5 (Ribosomal Protein of Leishmania major)Because it is to Treat or prevent or delay a Parasitic Disease in a subject； composition comprising a source of L3 and / or L5； use of the source for the in Vitro Diagnosis of illnessParasitic Ness in a subject； Diagnostic method； and its device.<；p>；Uso de una fuente de L3 y/o L5 (proteí；nas ribosomales de <；em>；Leishmania Major<；/em>；), porque es para tratar o prevenir o retrasar una enfermedad parasitaria en un sujeto； composició；n que comprende una fuente de L3 y/o L5； uso de dicha fuente para el diagnó；stico in vitro de una enfermedad parasitaria en un sujeto； mé；todo diagnó；stico； y su dispositivo.<；/p>；
